9058 POSTER A Phase II Trial of Eriotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) – a Galician Lung Cancer Group (GGCP) Study | Publicación